Site Selection for Life Sciences Companies in Europe
Choosing the right location when setting up or expanding operations is no easy task. Read our insights into the most important things to consider.
Read our insights into the key factors when choosing the right site for your operations.
Whether for your regional headquarters, shared service center, or your manufacturing, warehousing or R&D facility, there are many potentially attractive locations to consider.
In this fifth edition of Site Selection for Life Sciences Companies in Europe, we compare and contrast the European countries in terms of general business environment, infrastructure, innovation and R&D, availability of talent, and much more.
We also share our insights into latest developments. From the potential for Life Sciences businesses to benefit from EU funding and industrial strategies, to opportunities for contract manufacturers, to first-time product launches, our perspective can help you determine the optimal site for your operations.
Find out more about our key study findings.
A growth in industrial strategies
Discover the opportunities presented by a resurgence of state-led programs to stimulate economic growth and improve the resilience of critical industries such as Life Sciences.
A decline in tax relevance
Read how tax rates and incentives remain important, but BEPS 2.0’s planned minimum rates has demoted tax from its previous role as a primary driver of site selection.
A boost in industry capabilities
Find out why companies launching their first products are doing so without big pharma, as financing becomes easier to secure and the number of experienced advisors grows.
Your key contact
KPMG’s dedicated Life Sciences practice helps companies choose the right site for their unique needs. Talk to us if you are considering where to expand or set up your operations in Europe.
Interesting topics for you:
Site Selection for Life Sciences Companies in Asia
Navigate the landscape of Asia’s most dynamic and diverse Life Sciences markets.
We help pharmaceutical and biotech companies make better business decisions.
Our blog offers a clear picture of current trends and challenges facing the Swiss economy.